1389 GIGA-564 a third generation anti CTLA 4 with minimal ability to block CTLA 4 binding to B7 ligands has enhanced efficacy but reduced toxicity compared to ipilimumab in preclinical modelsErica Stone,Kyle Carter,Ellen Wagner,Michael Asensio,Emily Benzie,Yao Chiang,Garry Coles,Chelsea Edgar,Bishal Gautam,Ashley Gras,Jackson Leong,Renee Leong,Vishal Manickam,Rena Mizrahi,Ariel Niedecken,Jasmeen Saini,Savreet Sandhu,Jan Fredrick Simons,Kacy Stadtmiller,Brendan Tinsley,LaRee Tracy,Nicholas Wayham,Yoong Wearn Lim,David Johnson,Adam AdlerRegular and Young Investigator Award Abstracts（2022）引用 0|浏览18AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
